scholarly journals The Emerging Role of Community Pharmacists in Remote Patient Monitoring Services

Pharmacy ◽  
2020 ◽  
Vol 8 (3) ◽  
pp. 166
Author(s):  
Amina Abubakar ◽  
Jessica Sinclair

Remote physiologic monitoring (RPM) services involve the transmission of patient-collected physiologic data to the healthcare team. These data are then analyzed to determine what changes may be needed to enhance patient care. While pharmacists may not be recognized as billing providers through some payers, there are opportunities for pharmacist collaboration with providers to enhance patient access to RPM services. Community pharmacist services are traditionally tied to a product, but pharmacists are skilled in medication management, disease state evaluation, and patient counseling, which are skills that can contribute to an elevated RPM program.

CHEST Journal ◽  
2021 ◽  
Vol 159 (2) ◽  
pp. 477-478
Author(s):  
Neeraj R. Desai ◽  
Edward J. Diamond

2017 ◽  
Vol Volume 6 ◽  
pp. 137-143 ◽  
Author(s):  
Daniel Asfaw Erku ◽  
Sewunet Admasu Belachew ◽  
Abebe Basazn Mekuria ◽  
Kaleab Taye Haile ◽  
Begashaw Melaku Gebresillassie ◽  
...  

2018 ◽  
Vol 09 (01) ◽  
pp. 001-010 ◽  
Author(s):  
Karen Pellegrin ◽  
Francis Chan ◽  
Natalie Pagoria ◽  
Sheena Jolson-Oakes ◽  
Reece Uyeno ◽  
...  

Background While evidence generally supports the use of medication management technology, systems are typically implemented and evaluated piecemeal rather than as part of a comprehensive model for medication management. Systems to support drug therapy optimization, increasingly a key role of pharmacists in our healthcare system, have not yet been reported. Objective Our objective is to describe the design, implementation, and use of health information technology to support the hospital and community pharmacists' management of medications for high-risk patients statewide in the “Pharm2Pharm” model of care. Our aims were to make it easier for the pharmacists to access information needed to identify and resolve drug therapy problems using best practices for medication management and communicate with other members of the care team. Methods The pharmacist's roles and the medication management processes guided the design of the supporting technology, which was implemented after the Pharm2Pharm model was launched and the pharmacists' technology needs were assessed. Priorities for technology included sending care transition documents from hospital to community pharmacist securely and efficiently, access to medical records, including medications and laboratory results, documentation, and patient tracking. Implementation and use of the technology were documented. Results Communications, medication management, and population management solutions were implemented to support the Pharm2Pharm model. The pharmacists delivering services through this model adopted and meaningfully used this technology to support their work. Conclusion Implementing technology with value outside of the Pharm2Pharm model was a strategic approach to investment. This work emphasizes the importance of shifting the focus of technology from supporting a specific piece of the medication management process to supporting the goal of optimizing medication regimens. Health information exchange systems can provide important technology needed to integrate pharmacists into care teams as they are deployed to improve patient outcomes.


1994 ◽  
Vol 28 (2) ◽  
pp. 276-279 ◽  
Author(s):  
Ahuva Lustig ◽  
Shlomo P. Zusman

OBJECTIVE: To examine the sectoral differences among Israeli pharmacists regarding their perception of actual versus desired contact with other members of the healthcare team, and measures necessary to achieve a closer working relationship among members. DESIGN, SETTING, AND PARTICIPANTS: Pharmacists from private, community, and hospital sectors (n=145) completed a survey that assessed their respective views of the current and future roles of the pharmacist as a member of the healthcare team. MAIN OUTCOME MEASURES: Common to pharmacists in all three sectors is their aspiration for greater cooperation among members of the healthcare team, especially with physicians. Intersectoral differences were found in their attitude toward their role in the healthcare team: hospital phannacists would like a better relationship with patients, private pharmacists would like closer ties with physicians, and community pharmacists would like better teamwork with the nurse. No sectoral differences were seen in how pharmacists see themselves as members of the clinical healthcare team. Only 12 percent believe they have adequate knowledge to advise on clinical pharmacotherapy. To perform this function, they indicated that more training in pharmacotherapy would be needed (98.6 percent of respondents), as well as joint courses with medical students (84.2 percent), and a modification of their internship period requiring them to work in each of the different practice sectors (73.4 percent). No sectoral differences were observed regarding the benefits of a more active role of the pharmacist in the healthcare team. CONCLUSIONS: One possible explanation for Israeli pharmacists' low professional self-image, despite the rewards of the profession, is that they lack the necessary clinical knowledge that would enable them to take a more active role in the healthcare team. Pharmacists' job satisfaction may improve if a more active advisory role in the healthcare team can be achieved.


2021 ◽  
pp. OP.20.00995
Author(s):  
Mary Steimer ◽  
Jessica Leabo ◽  
Hongkun Wang ◽  
David Heyer ◽  
Nancy Addison ◽  
...  

PURPOSE: The COVID-19 pandemic has posed significant challenges in the care of patients with cancer, including how to manage outpatients who are COVID-positive but do not require hospitalization. We explored the use of a remote patient monitoring (RPM) program to care for such outpatients. METHODS: Consecutive patients who were tested for COVID-19 because of symptom onset but were clinically stable were offered enrollment into a pilot RPM program. Patients were provided equipment for vital sign measurements and a computer tablet to enter results three times per day. The results were monitored centrally by clinical staff. The goal was to closely monitor patients and escalate care as warranted. RESULTS: Between March and June of 2020, 29 patients were approached and 26 were enrolled. The mean age was 57 years old (range, 30-88), 14 were women, and patients remained in the program for an average of 16 days (range, 2-63). Twenty-four patients (83%) were on active anticancer therapy. During that time period, only one patient was admitted to the hospital for worsening respiratory symptoms. The percentage of days during which at least one set of data and all three sets of data were entered was 97.2% and 65.7%, respectively. There was no association between the demographic factors of age, sex, or the reason for being monitored with the level of engagement ( P > .05). CONCLUSION: In this pilot study, patients with cancer were readily enrolled in a remote home monitoring program. Monitoring was feasible, and there was a high rate of engagement with the program. The role of RPM should be further tested as the COVID pandemic continues.


2021 ◽  
Vol 115 (3) ◽  
pp. 168-177
Author(s):  
Amal Akour ◽  
Eman Elayeh ◽  
Razan Tubeileh ◽  
Alaa Hammad ◽  
Rawan Ya’Acoub ◽  
...  

2021 ◽  
pp. OP.21.00269
Author(s):  
Bobby Daly ◽  
Tara S. Lauria ◽  
Jessie C. Holland ◽  
Jericho Garcia ◽  
Jibran Majeed ◽  
...  

PURPOSE: Oncology patients are vulnerable to adverse outcomes associated with COVID-19, and clinical deterioration must be identified early. Several institutions launched remote patient monitoring programs (RPMPs) to care for patients with COVID-19. We describe patients' perspectives on a COVID-19 RPMP at a National Comprehensive Cancer Center. METHODS: Patients who tested positive for COVID-19 were eligible. Enrolled patients received a daily electronic COVID-19 symptom assessment, and a subset of high-risk patients also received a pulse oximeter. Monitoring was provided by a centralized team and was discontinued 14 days after a patient's positive test result and following 3 days without worsening symptoms. Patients who completed at least one assessment and exited the program were sent a patient engagement survey to evaluate the patient's experience with digital monitoring for COVID-19. RESULTS: The survey was distributed to 491 patients, and 257 responded (52% completion rate). The net promoter score was 85%. Most patients agreed that the RPMP was worthwhile, enabled better management of their COVID-19 symptoms, made them feel more connected to their healthcare team, and helped prevent emergency room visits. Identified themes regarding patient-perceived value of a RPMP included (1) security: a clinical safety net; (2) connection: a link to their clinical team during a period of isolation; and (3) empowerment: an education on the virus and symptom management. CONCLUSION: RPMPs are perceived to be of value to oncology patients with COVID-19. Policymakers should consider how these programs can be reimbursed to keep vulnerable patients at home and out of the acute care setting.


2021 ◽  
Vol 10 (1) ◽  
pp. 16-21
Author(s):  
P. Tasleem ◽  
M. Reshma ◽  
M. Sai Kiran ◽  
L. Reddenna ◽  
V. Sreedhar

Background of the study: Inaccuracy in writing and poor legibility of handwriting or incomplete writing of a prescription can lead to misinterpretation, thus leading to errors in dispensing and administration. Both individual and system related factors are responsible for prescribing errors. Recognition is the essential step in building safer systems and preventing errors. These errors can be detected by systematic analysis of prescriptions through a prescription audit. Hence, this project was proposed to improve the prescription practice by recommending the prescribing and therapeutic interventions in a selected setting of Anantapur. Research Methodology: The study was approved by the ethical committee of the hospital. Before starting the study, the researcher obtained formal permission from Government General Hospital, Anantapuramu. The data collection period was for 6 months. A prospective observational design was adopted for this study. The prescriptions were selected on the basis of inclusion criteria. Descriptive statistics like frequency and percentage were calculated to describe the data. Results and discussion: The overall observation made from this study was that clinical pharmacist could identify some drug related problems, provides clinical pharmacy services and contribute to better patient care being a part of the healthcare team. Conclusion: There is enormous scope for the clinical pharmacist to play an important role in health care in various aspects like monitoring ADRs, provision of drug information, identifying DRPs and patient counseling which will bring better patient outcome. Key words: Adverse drug reactions, Clinical audit, Clinical Pharmacist, prescription audit


Sign in / Sign up

Export Citation Format

Share Document